Outbreak of Acinetobacter baumannii bacteremia related to contaminated morphine used for patient-controlled analgesia

Infection Control and Hospital Epidemiology

Volumn 28, Issue 10, 2007, Pages 1213-1217

  Lee, Hsin Chun ^a   Lee, Nan Yao ^a,b   Chang, Chia Ming ^a,b   Chou, Cheng Yang ^a   Wu, Yi Hui ^c   Wang, Li Rong ^a   Ko, Nai Ying ^a   Liu, Ching Chuan ^a   Ko, Wen Chien ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL DNA; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LATAMOXEF; MORPHINE SULFATE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENETICS; BACTERIUM ISOLATE; BLOOD CULTURE; CLINICAL ARTICLE; DRUG CONTAMINATION; DRUG SYNTHESIS; ELECTRICITY; FEMALE; FEVER; GYNECOLOGY; HUMAN; INFECTION CONTROL; INFECTION RISK; OBSTETRICS; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PULSED FIELD GEL ELECTROPHORESIS; WARD; WATER SUPPLY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS INFECTION; DISEASE OUTBREAKS; DRUG CONTAMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHINE; SURGICAL PROCEDURES, OPERATIVE; TAIWAN; WATER SUPPLY;

EID: 35348850049     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/520741     Document Type: Article

References (10)

1. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in healthcare facilities. Clin Infect Dis 2006; 42:692-699.
2. Murray PR, Baron EJ, Pfaller MA, et al. Manual of Clinical Microbiology. 7th ed. Washington, DC: ASM Press; 1999.
3. National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing: 11th Informational Supplement. Villanova, PA: NCCLS; 1999:M100-S11.
4. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-2239.
5. Siegman-Igra Y, Jacobi E, Lang R, Schwartz D, Carmeli Y. Unexpected hospital-acquired bacteraemia in patients at low risk of bloodstream infection: the role of a heparin drip. J Hosp Infect 2005; 60:122-128.
6. Grohskopf LA, Roth VR, Feikin DR, et al. Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med 2001; 344:1491-1497.
7. Goetz AM, Rihs JD, Chow JW, Singh N, Muder RR. An outbreak of infusion-related Klebsiella pneumoniae bacteremia in a liver transplantation unit. Clin Infect Dis 1995; 21:1501-1503.
8. Ostrowsky BE, Whitener C, Bredenberg HK, et al. Serratia marcescens bacteremia traced to an infused narcotic. N Engl J Med 2002; 346:1529-1537.
9. Bennett SN, McNeil MM, Bland LA, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995; 333:147-154.
10. Kastango ES. Blueprint for implementing USP chapter 797 for compounding sterile preparations. Am J Health Syst Pharm 2005; 62:1271-1288.